Sagar Lonial, MD, on Clinical Implications of New Data on CAR T-Cell Treatments for Multiple Myeloma

Posted: Tuesday, December 8, 2020

Sagar Lonial, MD, of the Emory University School of Medicine, discusses what he sees as encouraging findings on second-generation CAR T-cell treatments, toxicity concerns, and the question of whether these therapies can be offered outside of centers that specialize in treating patients with multiple myeloma.